Malignant neoplasm of prostate C61

  • C61 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • The 2019 edition of ICD-10-CM C61 became effective on October 1, 2018.
  • This is the American ICD-10-CM version of C61 - other international versions of ICD-10 C61 may differ.
Use Additional:
  • code to identify:
  • hormone sensitivity status (Z19.1-Z19.2)
  • rising PSA following treatment for malignant neoplasm of prostate (R97.21)
Type 1 Excludes:
  • malignant neoplasm of seminal vesicle (C63.7)

Codes: = Billable

  • C61 Malignant neoplasm of prostate

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.